{"id":506513,"date":"2020-09-11T18:08:02","date_gmt":"2020-09-11T18:08:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=506513"},"modified":"2020-09-11T18:08:02","modified_gmt":"2020-09-11T18:08:02","slug":"mydriasis-market-size-share-trends-epidemiology-forecast-till-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/mydriasis-market-size-share-trends-epidemiology-forecast-till-2030_506513.html","title":{"rendered":"Mydriasis Market, Size, Share, Trends, Epidemiology Forecast till 2030"},"content":{"rendered":"
\"Mydriasis<\/a><\/p>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Mydriasis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Mydriasis, historical and forecasted epidemiology as well as the Mydriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

Mydriasis is the dilation of the pupil, which may be due to a non-physiological cause such as disease, trauma, drugs usage, or physiological pupillary response.<\/p>\n

Currently, dilation is achieved by topical and\/or intracameral administration of anticholinergic agents, sympathomimetic agents, or both, with the most commonly used being cyclopentolate, tropicamide, and phenylephrine. Topical mydriatic agents have been used for many years to dilate the pupil before cataract surgery. Moreover, ophthalmologists have been in search of new options to streamline the process of intraoperative mydriasis.<\/p>\n

The approved therapies are the only current treatment available in the market of mydriasis, and there is a dearth of novel products in the pipeline. Furthermore, Omidria is going to generate the highest revenue, followed by topical regimen and intracameral Injections. Along with these approved therapies, the approval of Nyxol, a topical eye drop for the treatment of reversal of mydriasis in the future, can also contribute to the market in the forecast period. <\/p>\n

Mydriasis Market Insight<\/strong><\/p>\n

Mydriasis market size in 7MM in 2017 was USD 104.52 million  <\/strong><\/a><\/p>\n

Mydriasis Market Drivers<\/strong><\/a><\/p>\n